v3.26.1
Condensed Consolidated Statements of (Loss) Income and Comprehensive (Loss) Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue        
Research and development collaborations $ 4,590 $ 48,726 $ 6,998 $ 75,836
Operating expenses:        
Research and development 27,435 34,449 61,892 70,187
General and administrative 19,335 14,951 34,404 31,936
Total operating expenses 46,770 49,400 96,296 102,123
Loss from operations (42,180) (674) (89,298) (26,287)
Other (expense) income:        
Interest income 3,287 3,426 5,998 6,850
Interest expense related to sale of future royalties (6,595) 0 (8,661) 0
Other income (expense), net 196 (621) 316 (572)
Total other (expense) income, net (3,112) 2,805 (2,347) 6,278
(Loss) income before income taxes (45,292) 2,131 (91,645) (20,009)
Income tax recovery (expense) 273 186 2,464 (310)
Net (loss) income (45,019) 2,317 (89,181) (20,319)
Other comprehensive (loss) income:        
Unrealized (loss) income on available for sale securities, net of tax of $0 (129) 66 (615) 612
Total other comprehensive (loss) income (129) 66 (615) 612
Comprehensive (loss) income $ (45,148) $ 2,383 $ (89,796) $ (19,707)
Net (loss) income per common share:        
Basic (in dollars per share) $ (0.62) $ 0.03 $ (1.21) $ (0.27)
Diluted (in dollars per share) $ (0.62) $ 0.03 $ (1.21) $ (0.27)
Weighted-average common stock outstanding:        
Basic (in shares) 72,993,313 75,337,168 73,826,423 75,254,553
Diluted (in shares) 72,993,313 77,378,449 73,826,423 75,302,357